Where to next in phosphonate research?

B. Grant

DOI: https://doi.org/10.1071/APP9900144

1990-12-01

Australasian Plant Pathology

Abstract:The papers presented at this workshop havedemonstrated the breadth and intensity of the research effort associated with the development of phosphonic acid as a fungicide in Australia, There is no doubt that phosphonlc acid is an enormously useful agent for the control of a range of diseases, With many of these, the use of an effective fungicide was not previously economical. It is clear that our knowledge of phosphonic acid as a fungicide is far from complete. Further research needs to be carried out in several different areas. The first, which should have absolute priority, is that it is necessary to obtain registration of phosphonic acid as a commercial fungicide in all States of Australia. This is well under way. but the need for completion is urgent. A considerable demand for phosphonic acid to treat a variety of diseases has built up as a result of word of mouth communication and, in many cases, it is being used without registration and with insufficient information about its limitations. This poses the very real threat of phosphonic acid being used against diseases for which it will prove ineffective, or in such a way as to maximise the likelihood of resistance developing. It IS important that we avoid this, or much of the excellent work already done will be wasted. It is also desirable to re-examine the spectrum of diseases against which phosphonate might prove effective. To date, phosphonate has been thought of as being primarily useful in the control of members of the fungal order Peronosporales. There are now results which suggest that it may be useful against a much wider spectrum of pathogens. The work showing control of Armillaria luteobubalina is just one example. How wide a spectrum of diseases might we expect phosphonate to control? Until there is a clear understanding of the mechanism of action, there is no theoretical model from which to make predictions. Studies in pure culture can go part of the way to establishing the spectrum of diseases which might be controlled. but not all of the way. Field trials must always be the final arbiter of efficacy. but these are expensive and, unless something is known of the way in which the agent to be tested works. planning to yield a definitive result can be difficult. Moreover, it is very important that the scientific community knows what field trials have been carried out, what conditions were used, and whether trials were successful. There is anecdotal information about efficacy of phosphonate, or lack of it, in the treatment of various diseases caused by organisms other than Oomycetes. This can be distracting, because it is often accepted as established fact by persons working in collateral areas. This can result in important